SELLAS Life Sciences (SLS) Asset Utilization Ratio (2013 - 2022)
SELLAS Life Sciences' (SLS) quarterly Asset Utilization Ratio came in at 0.04 in Q4 2022, down 82.0% year-on-year from 0.24 in Q4 2021, and up 24.0% on a QoQ basis from 0.03 in Q3 2022.
SELLAS Life Sciences (SLS) Asset Utilization Ratio (2013 - 2022) Analysis & Trends
SELLAS Life Sciences (SLS) has 6 years of Asset Utilization Ratio data on file, last reported at 0.04 in Q4 2022.
- On a quarterly basis, Asset Utilization Ratio fell 82.0% year-over-year to 0.04 in Q4 2022; TTM through Dec 2022 was 0.04, a 82.0% decrease from a year earlier, with the FY2022 full-year figure at 0.04, down 79.85% from the prior year.
- Asset Utilization Ratio for Q4 2022 stood at 0.04, up from 0.03 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for SLS reached as high as 0.55 in Q1 2020 and fell as low as 0.03 in Q3 2022.
- Historically, Asset Utilization Ratio has averaged 0.19 across 3 years, with a median of 0.19 in 2020.
- Across the five-year window, Asset Utilization Ratio surged 302.06% in 2021 and slumped 85.25% in 2022, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.06 in 2020, then soared by 302.06% to 0.24 in 2021, then sank by 82.0% to 0.04 in 2022.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.04 in Q4 2022, 0.03 in Q3 2022, and 0.04 in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.69 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | SELLAS Life Sciences | 1.96 Bn | 1.96 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | 0.12 |
| Dec 31, 2021 | 0.24 |
| Sep 30, 2021 | 0.23 |
| Jun 30, 2021 | 0.23 |
| Mar 31, 2021 | 0.18 |
| Dec 31, 2020 | 0.06 |
| Sep 30, 2020 | 0.20 |
| Jun 30, 2020 | 0.39 |
| Mar 31, 2020 | 0.55 |
| Jun 30, 2015 | 0.10 |
| Mar 31, 2015 | 0.10 |
| Dec 31, 2014 | 0.12 |
| Sep 30, 2014 | 0.12 |
| Jun 30, 2014 | 0.11 |
| Mar 31, 2014 | 0.10 |
| Dec 31, 2013 | 0.10 |
| Sep 30, 2013 | 0.06 |